Oncology Redefining the approach to cancer care – a mission to improv... Each year across Europe, 3.7 million people are diagnosed with a form of cancer, resulting in 1.9 million deaths, making cancer the
Views & Analysis Collaborate to simplify cancer trials and accelerate post-pa... How could simplifying the administration of clinical trials help cancer diagnosis, care, and treatment levels to exceed pre-pandemic levels?
Views & Analysis Unlocking health data to improve oncology outcomes As the largest single-payer healthcare system in Europe, the UK’s National Health Service (NHS) has a uniquely beneficial health data and real-world evidence (RWE) environment.
Views & Analysis Helsinn’s Riccardo Braglia on the patient perspective in can... Swiss cancer care company Helsinn has become unique in the industry by remaining a family business over three generations.
Digital The power of blockchain in cancer care transformation Over the course of the last decade blockchain technology has slowly filtered through from the underground to the mainstream IT world and beyond.
Views & Analysis The home advantage in cancer care The optimal cancer care pathway for this complex disease outside the hospital.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.